Zoetis promotes Glenn David to chief financial officer
He succeeds Paul Herendeen, who has resigned from the animal health company
Zoetis has promoted Glenn David to become its executive vice president and chief financial officer, effective immediately.
Previously serving as Zoetis’ senior vice president of finance operations, David will assume responsibility for the oversight of the company’s financial management, planning and global operations. As CFO, David will report directly to CEO Juan Ramón Alaix and become part of the Zoetis executive team.
David succeeds Executive Vice President and Chief Financial Officer Paul Herendeen, who resigned effective August 18, to accept the position of CFO at another public company.
“Glenn has been an accomplished financial and strategic leader for Zoetis and a trusted partner to me and the entire executive team since our IPO,” said Alaix. “Glenn’s strong financial acumen, deep understanding of our company’s business operations and ability to partner with our business leaders to improve overall company performance, make him the clear successor for this important position. With this natural transition of executive responsibility to such a high caliber executive, the board and I are confident we have ensured continued focus on delivering shareholder value.”
Paul Herendeen's contributions to Zoetis
“We thank Paul for his contributions to our company over the past two years. Paul leaves Zoetis a stronger company, better positioned with investors and set to deliver long-term, sustainable shareholder value,” said Alaix.
Herendeen said, “I have enjoyed working with the Zoetis team to help create a world-class global finance organization and demonstrate the company’s compelling value proposition to investors. Leaving Zoetis is a tough decision but I look forward to my next challenge. Glenn and I have worked side-by-side over the past two years, and I have tremendous respect for his financial expertise and knowledge of the company and industry. I leave knowing that with Juan Ramón, Glenn and the rest of the Zoetis leadership team, the company is well-positioned to continue to grow and build on its position as the world leader in animal health.”
Herendeen will remain available to Zoetis to facilitate a smooth transition of duties.
Glenn David an experienced strategic and financial leader
With more than 20 years of experience in finance and operations, David has played a key role in leading the financial operations for Zoetis since its initial public offering (IPO) in 2013. As senior vice president of Finance Operations for Zoetis, David led a diverse global team of finance professionals including financial planning, analysis and support across its approximately 45 global markets; Treasury; Finance Shared Services and Global Operations. From April 2014 through August 2014, David served as acting chief financial officer of Zoetis, overseeing financial management, reporting, shareholder relations, global procurement and operations.
Before the Zoetis IPO, David served in various financial roles at Pfizer, including vice president of Global Finance for Pfizer Animal Health and vice president of finance for the U.S. Primary Care franchise. David also played important financial roles in Pfizer’s integration of the Pharmacia, Wyeth and King Pharmaceuticals’ acquisitions.
Prior to joining Pfizer in 1999, David held financial positions at Bankers Trust, Paine Webber and Credit Suisse. He graduated with a bachelor’s degree in Finance from Binghamton University, and earned his MBA from New York University.